Fibrosis Foundation Cystic serves as Executive at BiomX Inc., where they oversee executive responsibilities. Since joining the company, Fibrosis Foundation Cystic has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 15, 2024 involved exercising options for 4,778,265 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 15, 2024 | PHGE | $0 | Exercise | 4,778,265 | $N/A | Discretionary |
Fibrosis Foundation Cystic currently holds 9,330,580 shares of BiomX Inc. (PHGE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Fibrosis Foundation Cystic has been a net neutral trader of PHGE stock. They have purchased $0 and sold $0 worth of shares.
Fibrosis Foundation Cystic's most recent insider trade was on May 15, 2024, when they sold 4,778,265 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted